In the current fiscal environment, everything in the U.S. budget is open to scrutiny. Fortunately for the biodefense industry, protecting the nation from bioterrorism tends to have bipartisan support, especially when potential threats get extensive news coverage. Read More
CHICAGO – It was certainly an interesting week for Canada's biotechnology industry, with two big pharmas using the BIO 2013 International Convention to make announcements about their investments in the nation's research and development. Read More
